Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences' '05 Losses Widen 3.7 Percent on Shriveled Sales

This update serves to correct the reported net loss and clarify Proteome Sciences' expectation that protein biomarkers may be used to accelerate drug development and reduce costs.
 
NEW YORK (GenomeWeb News) - Proteome Sciences said full-year 2005 net losses increased 3.7 percent to £4.17 million ($7.7 million) from £4.02 million year over year.
 
The preliminary year-end report, released yesterday, also showed that total revenue slumped more than 77 percent to £16,200 from £73,000 a year ago.
 
Explaining the slump, Proteome Sciences CEO Christopher Pearce said adoption of protein-related technology was slower than expected and some deals scheduled to close at year-end were delayed.
 
However, the company has seen a significant increase in the number of pharmaceutical companies that have approached it during the first half of 2006.
 
Proteome Sciences said it expects protein biomarkers to accelerate drug development and reduce costs, and said its highest priority is to expand its licensing program to other companies.
 
The company had cash and equivalents of £2.6 million at year's end.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.